(Q37808645)

23 August 2017

title

Current advances in understanding of immunopathology of atherosclerosis (English)

1 reference

23 August 2017

1 reference

2

Yuri V Bobryshev

1 reference

23 August 2017

Colin-John Perrins

1

1 reference

23 August 2017

publication date

11 November 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

458

1 reference

23 August 2017

issue

2

1 reference

23 August 2017

page(s)

117-123

1 reference

https://scigraph.springernature.com/pub.10.1007/s00428-010-1006-5

23 August 2017

exact match

0 references

cites work

The discovery of cellular immunity in the atherosclerotic plaque

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Atherosclerosis--an immune disease: The Anitschkov Lecture 2007.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Participatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic cells and their role in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Inflammation and atherosclerosis: novel insights into plaque formation and destabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

The pathogenesis of atherosclerosis: a perspective for the 1990s

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Hallmarks of atherosclerotic lesion development with special reference to immune inflammatory mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

The vascular-associated lymphoid tissue: a new site of local immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Autoimmune and inflammatory mechanisms in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Monocyte recruitment and foam cell formation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Immune-mediated mechanisms in atherosclerosis: prevention and treatment of clinical manifestations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic cells in atherosclerosis: current status of the problem and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Vascular dendritic cells as gatekeepers of lipid accumulation within nascent atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic cells: immune regulators in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Tolerogenic dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Cross-presentation, dendritic cell subsets, and the generation of immunity to cellular antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic cell-mediated T cell polarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Regulation of MHC II and CD1 antigen presentation: from ubiquity to security.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic cells in atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Steady-state and inflammatory dendritic-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic cell subsets in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Most lymphoid organ dendritic cell types are phenotypically and functionally immature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Blood monocytes: development, heterogeneity, and relationship with dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Toll-like receptor-4 and mitogen-activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic cells pulsed with malondialdehyde modified low density lipoprotein aggravate atherosclerosis in Apoe(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Friendly and dangerous signals: is the tissue in control?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

21 January 2018

The biology of NKT cells

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

HMG-CoA reductase inhibitors suppress maturation of human dendritic cells: new implications for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Production of type I interferons: plasmacytoid dendritic cells and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

The yin and yang of type I interferon activity in bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

NKT cells: T lymphocytes with innate effector functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Natural killer T cells as targets for immunotherapy of autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Vaccination against atherosclerosis? Induction of atheroprotective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Human dendritic cell subsets for vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00428-010-1006-5

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

21 January 2018

1 reference

12 December 2020

Detection of activated T lymphocytes in the human atherosclerotic plaque

1 reference

12 December 2020

Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques

1 reference

12 December 2020

Promise of immune modulation to inhibit atherogenesis

1 reference

12 December 2020

Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

1 reference

12 December 2020

Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques

1 reference

12 December 2020

Identification of dendritic cells in aortic atherosclerotic lesions in rats with diet-induced hypercholesterolaemia

1 reference

12 December 2020

The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice

1 reference

12 December 2020

Functional profile of activated dendritic cells in unstable atherosclerotic plaque

1 reference

12 December 2020

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

1 reference

12 December 2020

Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves

1 reference

12 December 2020

Distinct Roles of Dendritic Cells and B Cells in Va14Ja18 Natural T Cell Activation In Vivo

1 reference

12 December 2020

Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment?

1 reference

12 December 2020

Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis

1 reference

12 December 2020

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

1 reference

12 December 2020

Can dendritic cells be exploited for therapeutic intervention in atherosclerosis?

1 reference

12 December 2020

Dendritic cells in vivo: a key target for a new vaccine science

1 reference

12 December 2020

Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice

1 reference

12 December 2020

10.1007/S00428-010-1006-5

Identifiers

DOI

1 reference

23 August 2017

1 reference